Hanru Ren
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Peptidase Inhibition and Analysis
Papers in
- Co-authors
- Xiaojing Yang (19 shared papers)Jie Fu (12 shared papers)Xiaomao Guo (2 shared papers)Chaosu Hu (2 shared papers)Baoqing Yu (3 shared papers)Xueyu Chen (3 shared papers)Hui Shi (3 shared papers)Yao Li (2 shared papers)
- Journals
- BMC Musculoskeletal Disorders (2 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)Journal of Orthopaedic Surgery and Research (2 papers)Journal of Cancer (2 papers)
- Partner nations
- China
In The Last Decade
Hanru Ren
28 papers receiving 399 citations
Peers
Comparison fields: 5 of 73
- Otorhinolaryngology 34
- Oncology 91
- Cancer Research 50
- Radiology, Nuclear Medicine and Imaging 71
- Genetics 31
Countries citing papers authored by Hanru Ren
This map shows the geographic impact of Hanru Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanru Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanru Ren more than expected).
Fields of papers citing papers by Hanru Ren
This network shows the impact of papers produced by Hanru Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanru Ren. The network helps show where Hanru Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanru Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 96 | |
| 2 | 2021 | 38 | |
| 3 | 2014 | 33 | |
| 4 | 2018 | 24 | |
| 5 | 2017 | 22 | |
| 6 | 2015 | 20 | |
| 7 | 2020 | 19 | |
| 8 | 2022 | 17 | |
| 9 | 2019 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2014 | 13 | |
| 12 | 2020 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2020 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2023 | 4 |
About Hanru Ren
Hanru Ren is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 29 papers that have together received 400 indexed citations. Recurring topics across this work include Hip and Femur Fractures (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Cancer-related gene regulation (3 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers), Pelvic and Acetabular Injuries (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Otorhinolaryngology (34 citations), Oncology (91 citations), Cancer Research (50 citations), Radiology, Nuclear Medicine and Imaging (71 citations) and Genetics (31 citations). Hanru Ren has collaborated with scholars based in China. Frequent co-authors include Xiaojing Yang, Jie Fu, Xiaomao Guo, Chaosu Hu, Baoqing Yu, Xueyu Chen, Hui Shi, Yao Li, Weiwei Yu and Yi Sun. Their work appears in journals such as BMC Musculoskeletal Disorders, Frontiers in Oncology, Oncotarget, Journal of Orthopaedic Surgery and Research and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.